Ludwig Enterprises Inc (OTC:LUDG) Enters Booming Artificial Intelligence Cancer Screening Market with its Non-Invasive Cancer Diagnostics Testing Kit, launching within 2024
March 19, 2024 08:00 ET
|
Ludwig Enterprises, Inc.
SPARKS, Nev., March 19, 2024 (GLOBE NEWSWIRE) -- Ludwig Enterprises, Inc, (OTC: LUDG): A US-based biotechnology company is pleased to announce it has entered the booming artificial intelligence...
Ludwig Enterprises Inc. (OTC:LUDG) Announces Patent Filing for Breakthrough in Identifying mRNA Genes Associated with Certain Cancers
March 06, 2024 08:00 ET
|
Ludwig Enterprises, Inc.
Ludwig Enterprises, Inc. (OTC: LUDG): A US-based biotechnology company is pleased to announce the successful filing of its provisional patent
Non-muscle Invasive Bladder Cancer (NMIBC) Epidemiology Forecasts to 2034
January 25, 2024 09:04 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Non-muscle Invasive Bladder Cancer (NMIBC) - Epidemiology Forecast - 2034" report has been added to ResearchAndMarkets.com's offering. The...
Oncology Nutrition Market Experiences Growth with Rise in Personalized and Immuno-nutrition Trends
January 22, 2024 21:28 ET
|
Research and Markets
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Oncology Nutrition Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The recent comprehensive analysis within...
Non-Muscle Invasive Bladder Cancer Market Analysis, Competitive Landscape, Growth Factors, Revenue & Forecasts, 2023-2030 – Published Study by RationalStat
November 27, 2023 06:45 ET
|
Rationalstat LLC
Wilmington, Delaware, Nov. 27, 2023 (GLOBE NEWSWIRE) -- According to RationalStat’s most recent industry analysis, the Global Non-Muscle Invasive Bladder Cancer Market value is estimated at US$ 2.5...
Intelligent Scopes Corp, Subsidiary of Claritas HealthTech, to Lead Global Delivery of CystoSmart™, an AI-Assisted Diagnostic Software for Bladder Cancer Detection in Endoscopic Images
November 12, 2023 19:13 ET
|
Claritas HealthTech Ltd
Intelligent Scopes Corp, Subsidiary of Claritas HealthTech, to Lead Global Delivery of CystoSmart™, an AI-Assisted Diagnostic Software for Bladder Cancer
Bladder Cancer Treatment Market is expected to hit USD 7.52 Bn by 2029 at a CAGR of 9.2 percent – says Maximize Market Research
May 30, 2023 08:08 ET
|
MAXIMIZE MARKET RESEARCH PRIVATE LIMITED
Pune, May 30, 2023 (GLOBE NEWSWIRE) -- A global Healthcare research and business-consulting firm, Maximize Market Research, has published a market intelligence report on the “Bladder Cancer...
Theralase® Releases FY2022 Audited Financial Statements
April 26, 2023 18:01 ET
|
Theralase Technologies Inc.
TORONTO, April 26, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research...
Theralase® Phase II NMIBC Clinical Study (Interim) Data Presented at the ASCO GU Cancer Symposium
February 23, 2023 07:00 ET
|
Theralase Technologies Inc.
TORONTO, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the research...
Criterium, Inc. Announces Formation of New Oncology Research Consortium for Genito-Urinary Indications
January 26, 2023 09:30 ET
|
Criterium Inc.
SARATOGA SPRINGS, N.Y., Jan. 26, 2023 (GLOBE NEWSWIRE) -- Criterium, Inc., a full-service Contract Research Organization (CRO), is pleased to announce AURIC (Academic Urology Research Investigators...